Schonfeld Strategic Advisors LLC Procept Bio Robotics Corp Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 6,000 shares of PRCT stock, worth $408,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,000Holding current value
$408,540% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding PRCT
# of Institutions
217Shares Held
36.3MCall Options Held
251KPut Options Held
101K-
Vanguard Group Inc Valley Forge, PA4.71MShares$321 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$237 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.81MShares$123 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.75MShares$119 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.37MShares$93 Million0.53% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.04B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...